Innovations Spotlight

Medical Innovation: An Absolute Priority

02/06/2017

Medical Innovation: An Absolute Priority

Aram Nerpouni – President & CEO of BioEnterprise— recently penned an article, New leaders need to understand importance of funding medical innovation.  Cleveland Clinic Innovations is proud to work with local organizations like BioEnterprise to advance healthcare and create economic opportunity.


Researchers Discover How Glioblastoma Stem Cells Evade the Immune System

01/24/2017

Researchers Discover How Glioblastoma Stem Cells Evade the Immune System

Breakthrough research conducted at Cleveland Clinic’s Lerner Research Institute sheds light on how certain cancer stem cells (CSCs) evade the immune system.  As explained in a paper published on line January 12 in Cell Stem Cell, glioblastoma stem cells express a lower level of the innate toll-like immune receptor 4 (TLR4) than surrounding cells.


First Implant of a Transcatheter Tricuspid Valved Stent Marks New Frontier in Percutaneous Valve Care

01/19/2017

First Implant of a Transcatheter Tricuspid Valved Stent Marks New Frontier in Percutaneous Valve Care

Transcatheter heart valve replacement has just expanded to a new front: A Cleveland Clinic team successfully performed the world’s first implantation of a transcatheter tricuspid valved stent.


Cleveland Clinic Experts Explore the Curious Links Between Cancer, Autism, and our Genome

01/19/2017

Cleveland Clinic Experts Explore the Curious Links Between Cancer, Autism, and our Genome

The field of genomics is moving at an incredible pace. Cleveland Clinic is proud to have some of the foremost genomic researchers and innovators at our campus, all eager to get to the root of diseases like cancer, heart disease, Alzheimer’s and more.


Cleveland Clinic Mouth Guard Technology Turns Heads at the 2017 Consumer Electronics Show

01/17/2017

Cleveland Clinic Mouth Guard Technology Turns Heads at the 2017 Consumer Electronics Show

Concussions have always been a risk in high impact sports, but our understanding of how to measure and treat these injuries has been elusive. Prevent Biometrics, a Cleveland Clinic spin-off, is helping answer those questions.


Forbes Names Top 10 Medical Innovations Among Top Science Lists of 2016

01/09/2017

Forbes Names Top 10 Medical Innovations Among Top Science Lists of 2016

Every year, or every day for that matter, lists are published touting the best new something. For the past 11 years, we have published our Top 10 Medical Innovations, a list of technologies poised to make a  breakthrough in the following year.


Cleveland Clinic Performs World’s First DBS Surgery for Stroke Recovery

01/09/2017

Cleveland Clinic Performs World’s First DBS Surgery for Stroke Recovery

Cleveland Clinic has performed the first deep brain stimulation (DBS) surgery in a patient for the purpose of restoring motor function following ischemic stroke.


2016 Medical Innovation Summit Welcomes 2,250 to Cleveland to Accelerate Healthcare

12/05/2016

2016 Medical Innovation Summit Welcomes 2,250 to Cleveland to Accelerate Healthcare's Transformation

The 2016 Medical Innovation Summit started with a call to action:

"Every damn moment counts. And every moment we delay matters.” – Vice President Joe Biden
 


Jack Miner is All In for Cleveland Clinic Ventures

12/05/2016

Jack Miner is All In for Cleveland Clinic Ventures

It didn’t take long for Jack Miner to fit into the city of Cleveland. When he joined Cleveland Clinic Innovations as the new Managing Director for Cleveland Clinic Ventures this September, he had no idea that his mantra of “All In” already had a special place in the heart of Clevelanders.  The slogan of the Cavs’ historic championship win is now flying on a banner in his office, but he has plans for these two words go beyond basketball.
 


Making the Most out of the First Money In

10/21/2016

Making the Most out of the First Money In

For the last decade, there has been a conservative shift in how much investors and industry are willing to gamble on a novel medical technology. While risk-adverse approaches have potentially discouraged investors on a national level,  Cleveland Clinic Innovations has seen virtually no impact on the flow of ideas that are disclosed from our caregivers on the front lines of healthcare delivery. This has led to the question, what do we do with a portfolio of promising early ideas if the market isn’t ready to invest in them?  In our case, the answer is simple: We build them. 



 


 <  4 5 6 7 8 9 10 11 12 13  > 

Get In Touch With Us